doi: 10.1007/s12020-021-02770-6 Pubmed Abstract CrossRef Google Scholar View reference in article 5 MuruganAKAlzahraniAS
Oral semaglutide beyond glycemic control Efficacy and safety of oral semaglutide versus other GLP1-RA drugs A systematic literature review used a network meta-analysis tool to calculate the relative efficacy and safety of once-daily oral semaglutide 14 mg versus dulaglutide 1.5 mg, twice-daily exenatide 10 g, once-weekly exenatide 2 mg, once-daily liraglutide 1.8 mg, once-daily lixisenatide 20 g, and once-weekly injectable semaglutide 0.5 and 1.0 mg (all GLP-1 RA class drugs) using seven clinical trials [50]
This formula combines NMNH and ergothioneine, NMNH as an NAD Supplement, It is good for healthy aging, skin health, immune system, boosts NAD+, cellular health, DNA repair, and energy level Ergothioneine is a naturally occurring antioxidant compound found in mushrooms such as lions mane
However, caution should be given to this review because most studies were from high-income countries and insulin degludec/liraglutide (IDegLira) was included in the GLP-1RA group